Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma.
Teruhito TakakuwaYusuke OkayamaHirohisa NakamaeMasatomo KunoYosuke MakuuchiNaonori HaradaHiroshi OkamuraMitsutaka NishimotoYasuhiro NakashimaHideo KohMasayuki HinoPublished in: Annals of hematology (2022)